Juvenile Membranous Nephropathy Developed after Human Papillomavirus (HPV) Vaccination

A 16-year-old girl with no history of renal disease had a fever of 38 °C after her second HPV vaccination and was identified as positive for proteinuria. As she maintained urinary protein of 3.10 g/gCr and 5–9 urinary red blood cells/HPF, a renal biopsy was performed and small spikes on PAM staining with the granular deposition of IgG1++ and IgG3+ on the glomerular capillary wall were discovered by immunofluorescence, although PLA2R immunostaining was negative. Analysis by electron microscope showed electron density deposition in the form of fine particles under the epithelium. The diagnosis was secondary membranous nephropathy stage II. Immunostaining with the anti-p16 INK4a antibody was positive for glomerular cells, and Western blot analysis of urinary protein showed a positive band for p16 INK4a. However, laser-microdissection mass spectrometry analysis of a paraffin section of glomeruli failed to detect HPV proteins. It is possible that the patient was already infected with HPV and administration of the HPV vaccine may have caused secondary membranous nephropathy.

[1]  T. Ishimitsu,et al.  AL-Kappa Primary Amyloidosis with Apolipoprotein A-IV Deposition , 2022, Internal medicine.

[2]  T. Caza,et al.  How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy , 2021, Frontiers in Immunology.

[3]  Yong Jin Kim,et al.  New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review , 2021, Journal of Korean medical science.

[4]  M. Vankalakunti,et al.  Nephrotic Syndrome Following ChAdOx1 nCoV-19 Vaccine Against SARScoV-2 , 2021, Kidney International Reports.

[5]  G. Garosi,et al.  Minimal change disease following vaccination for SARS-CoV-2 , 2021, Journal of Nephrology.

[6]  R. Maas,et al.  An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine , 2021, American Journal of Kidney Diseases.

[7]  A. Tobar,et al.  Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine , 2021, American Journal of Kidney Diseases.

[8]  B. Rovin,et al.  Gross Hematuria Following Vaccination for SARS-CoV2 in Two Patients with IgA Nephropathy , 2021, Kidney International.

[9]  S. Grénman,et al.  Oral Human Papillomavirus Infection in Children during the First 6 Years of Life, Finland , 2021, Emerging infectious diseases.

[10]  S. Sethi New 'Antigens' in Membranous Nephropathy. , 2020, Journal of the American Society of Nephrology : JASN.

[11]  N. Matsumura,et al.  Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan , 2020, Cancer science.

[12]  A. Hidalgo-Miranda,et al.  The Human Papillomavirus (HPV) E1 protein regulates the expression of cellular genes involved in immune response , 2019, Scientific Reports.

[13]  M. Sekine,et al.  HPV vaccination in Japan: what is happening in Japan? , 2019, Expert review of vaccines.

[14]  T. Okuhara,et al.  Contents of Japanese pro- and anti-HPV vaccination websites: A text mining analysis. , 2017, Patient education and counseling.

[15]  R. Stahl,et al.  Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents , 2018, Pediatric Nephrology.

[16]  Hang Li,et al.  Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents. , 2017, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

[17]  T. Nakayama An inflammatory response is essential for the development of adaptive immunity-immunogenicity and immunotoxicity. , 2016, Vaccine.

[18]  H. Shah,et al.  Membranous nephropathy and severe acute kidney injury following influenza vaccination. , 2015, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[19]  K. Egawa,et al.  Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia , 2015, Viruses.

[20]  Y. Wang,et al.  Clinicopathological analysis of idiopathic membranous nephropathy in young adults. , 2015, Genetics and molecular research : GMR.

[21]  A. Farhadi,et al.  High‐risk human papillomavirus infection in different histological subtypes of renal cell carcinoma , 2014, Journal of medical virology.

[22]  Y. Kashiwagi,et al.  Inflammatory responses following intramuscular and subcutaneous immunization with aluminum-adjuvanted or non-adjuvanted vaccines. , 2014, Vaccine.

[23]  A. D. De Paul,et al.  Minimal change disease following influenza vaccination and acute renal failure: just a coincidence? , 2012, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[24]  Y. Aydın,et al.  Can influenza H1N1 vaccination lead to the membranous glomerulonephritis? , 2012, Indian journal of pathology & microbiology.

[25]  R. Gherardi,et al.  Macrophagic myofasciitis: characterization and pathophysiology , 2012, Lupus.

[26]  Y. Shoenfeld,et al.  'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. , 2011, Journal of autoimmunity.

[27]  R. Fisher,et al.  Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Y. Shoenfeld,et al.  Vaccines and Autoimmunity , 2013, International journal of immunopathology and pharmacology.

[29]  V. Bröcker,et al.  Minimal change nephrotic syndrome in an 82 year old patient following a tetanus-diphteria-poliomyelitis-vaccination , 2009, BMC nephrology.

[30]  S. Rosso,et al.  Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial. , 2008, The Lancet. Oncology.

[31]  S. Franceschi,et al.  Human papillomavirus and HPV vaccines: a review. , 2007, Bulletin of the World Health Organization.

[32]  Kwong-Kum Liao,et al.  Guillain–Barré syndrome coexisting with pericarditis or nephrotic syndrome after influenza vaccination , 2004, Clinical Neurology and Neurosurgery.

[33]  A. Melk,et al.  Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. , 2004, Kidney international.

[34]  E. Gabusi,et al.  Increased expression of p16(INK4a) and p27(Kip1) cyclin-dependent kinase inhibitor genes in aging human kidney and chronic allograft nephropathy. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  F. Nakhoul,et al.  Influenza vaccination induced leukocytoclastic vasculitis and pauci-immune crescentic glomerulonephritis. , 2002, Clinical nephrology.

[36]  Y. Kikuchi,et al.  Minimal change nephrotic syndrome, lymphadenopathy and hyperimmunoglobulinemia after immunization with a pneumococcal vaccine. , 2002, Clinical nephrology.

[37]  V. Kliem,et al.  Minimal change nephrotic syndrome in a 65-year-old patient following influenza vaccination. , 2000, Clinical nephrology.

[38]  M. Çakır,et al.  Nephrotic syndrome following hepatitis B vaccination. , 2000, Pediatric nephrology.

[39]  P. Laforêt,et al.  Macrophagic myofasciitis: an emerging entity , 1998, The Lancet.

[40]  J. Best,et al.  Perinatal infection and persistence of human papillomavirus types 16 and 18 in infants , 1995, Journal of medical virology.

[41]  E. Keystone,et al.  Systemic vasculitis following influenza vaccination--report of 3 cases and literature review. , 1993, The Journal of rheumatology.

[42]  U. Patel,et al.  Drug points: Henoch-Schönlein purpura after influenza vaccination , 1988 .

[43]  U. Patel,et al.  Drug points: Neutropenia following intravenous immunoglobulin , 1988 .

[44]  H. L. Barnett International study of kidney disease in children. , 1979, Nihon Jinzo Gakkai shi.

[45]  Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. , 1978, Kidney international.